American Oncology Network, Inc.
American Oncology Network, Inc. (DTOC) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 1 transactions totaling $2.2M, demonstrating a bearish sentiment with -$2.2M in net insider flow. The most recent transaction on Sep 25, 2023 involved a sale of 205,512 shares valued at $2.2M.
DTOC Recent Transactions
1 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | Management, L.p. Saba Capital | Executive | Sale | 205,512 | $10.50 | $2.2M | Large |
DTOC Insider Activity Summary
Who Is Buying DTOC Stock?
No significant insider buying has been recorded for DTOC in the recent period.
Who Is Selling DTOC Stock?
No significant insider selling has been recorded for DTOC in the recent period.
Is American Oncology Network, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for DTOC is bearish with an Insider Alignment Score of 0/100 and a net flow of -$2.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
DTOC Frequently Asked Questions
Understanding DTOC Insider Activity
Insider trading at American Oncology Network, Inc. (DTOC) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading DTOC stock, having executed 1 transactions in the past 90 days. The most active insider is Capital Management, L.p. Saba (Executive), who has made 1 transactions totaling $2.2M.
Related Tools
Track American Oncology Network, Inc. Insider Activity
Get notified when executives and directors at DTOC file new Form 4 transactions